Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing ...
TIKOSYN® (dofetilide) is for patients with irregular heartbeats such as atrial fibrillation (AF) and atrial flutter (AFL). See the risks & benefits.
Find patient medical information for Dofetilide Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Sep 6, 2017 ... Easy to read patient leaflet for Dofetilide. Includes indications, proper use, special instructions, precautions, and possible side effects.
Jan 10, 2017 ... (dofetilide) Capsules. WARNING. To minimize the risk of induced arrhythmia, patients initiated or re-initiated on TIKOSYN should be placed for ...
Medscape - Atrial fibrillation dosing for Tikosyn, (dofetilide), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jan 15, 2016 ... Dofetilide: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Dofetilide is an oral class III antiarrhythmic agent used for treatment and prevention of atrial fibrillation and flutter. Dofetilide has had limited clinical use, but has ...
Dofetilide is a new antiarrhythmic drug that recently was recommended for approval by an advisory committee to the Food and Drug Administration (FDA) for ...